Please provide your email address to receive an email when new articles are posted on . A group of experts updated the FITTER insulin injection recommendations for the first time since 2016. The ...
The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients with type 2 diabetes as a complement to diet and exercise. The FDA today ...
(BPT) – Diabetes Alert Day on March 25 is more than just a date on the calendar — it’s a wake-up call for millions of Americans who either live with diabetes or are at risk of developing it. It’s a ...
Add Yahoo as a preferred source to see more of our stories on Google. Weekly insulin shots can help control both Type 1 and Type 2 diabetes as well as daily injections do, a pair of clinical trials ...
The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control in patients ages 10 and older with type 2 diabetes, used as an adjunct to ...
SOUTH SAN FRANCISCO, Calif.-- (BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved Lucentis ® ...
Continuous administration of ranibizumab with a port delivery system provides an alternative to frequent intravitreal injections for diabetic macular edema and helps delay progression of ...
Insulin icodec, a once-weekly basal injection to treat type 1 diabetes, has the potential to be as effective in managing the condition as daily basal insulin treatments, according to new research. The ...
Most of the 38 million people living with diabetes in the U.S. use daily injections or insulin pumps to keep glucose at safe levels — but new research suggests that a third option could be just as ...
Endocrinologists have debunked widespread myths surrounding the use of insulin in the management of diabetes, describing insulin injection as a life-saving treatment essential for controlling blood ...
Weekly insulin shots can help control both Type 1 and Type 2 diabetes as well as daily injections do, a pair of clinical trials have found. A new class of insulin called efsitora alfa has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results